3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
1
Interventions
Specimen Handling
218
pembrolizumab
200
Magnetic Resonance Spectroscopy
196
Carboplatin
173
Cisplatin
137
Biopsy
133
Nivolumab
131
Paclitaxel
116
Cyclophosphamide
113
Radiotherapy
110
Gemcitabine
103
Dexamethasone
91
durvalumab
90
atezolizumab
76
Radiation
71
Lenalidomide
71
Rituximab
68
Pemetrexed
67
Doxorubicin
67
Bevacizumab
65
Docetaxel
62
Ipilimumab
59
Etoposide
56
olaparib
55
Fluorouracil
52
venetoclax
51
Radiosurgery
50
Oxaliplatin
50
Taxes
49
Prednisone
48
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Bupropion
×
90 days
×
Clear all
NCT05646862
2026-05-06
INAVO121
Hoffmann-La Roche
Phase 3
Active not recruiting
420 enrolled